Vascular Biogenics Ltd (VBLT)

[Oren1976]

And we don't talk about small sample. Small sample can explain rare results but here the sample is not small. We have success in around 170 and ovarian wasn't just a success but big success. Not only the sample is far from being small the cancer types say everything . Ovarian is a deadly disease u have around 6 months to live in platinum resistant it's not in the friendly cancer category . Ovarian is a very very devastating disease . Vb111 not only passed the sample size it passed also the cancer types but most of all it worked in 3 different cancers 3 phase twos passed . It leaves zero chance to fail in phase 3